Status:
UNKNOWN
A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve
Lead Sponsor:
Nanjing University
Conditions:
Poor Ovarian Response
Eligibility:
FEMALE
21-42 years
Phase:
NA
Brief Summary
Assisted reproductive technology (ART), especially controlled ovarian stimulation (COS), significantly increased clinical pregnancy rates among infertile patients. However, about 9% to 24% of patients...
Eligibility Criteria
Inclusion
- Age less than or equal to 42 years old, AFC\<5 and or AMH\<1.2ng/ml ② Adopt antagonist program for controlled ovulation hyperstimulation (COH); patients with fresh cycle transplantation;
- Accept conventional IVF or intracytoplasmic sperm injection (ICSI);
- The ART treatment cycle is less than 3 times.
Exclusion
- Abnormal chromosome karyotype;
- Severe endometriosis;
- Abnormal thyroid function; ④ Pregnancy contraindications; ⑤ Past history of ovarian tumors or after receiving radiotherapy
Key Trial Info
Start Date :
January 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT04717752
Start Date
January 20 2021
End Date
December 31 2021
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China, 210008